By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardinal Health (North Carolina) 

160 Magellan Lab Court

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-481-4855 opt. 2 Fax:


Cardinal Health is the global leader in providing outsourced pharmaceutical development services, drug delivery technologies, contract manufacturing, packaging and product commercialization services, serving the worldwide pharmaceutical and biotechnology industries. With proven expertise and a long history of innovation, Cardinal Health helps its customers accelerate their development process, streamline their supply chain, and extend the life of their products. Cardinal Health also offers the broadest range of dose form development and manufacturing options in the industry--from traditional and proprietary oral forms to sterile products, from inhaled forms to topicals.

Cardinal Health offers a range of services, such as pre-clinical support, API development, analytical services, drug delivery development, clinical manufacturing and packaging services. We have expertise in inhalation development, and can offer innovative cell-line development using our proprietary GPEx™ technology.

We provide a wide range of scientific and regulatory consulting services required to obtain marketing approval for drugs, biologics and medical devices in the U.S., Canadian, Asian and European markets.

Drug Delivery:
Cardinal Health holds more than 1,500 patents and patent applications for drug delivery systems. Our drug delivery technologies include soft gelatin capsules, Zydis® fast dissolve dosage form; EnCirc®, EnVel®, and EnSolv® for oral modified release products; lyophilization; inhaled technologies (MDI, DPI, nasal sprays); and topical Microsponge® for timed release and DelPouch® for unit dosing.

We provide manufacturing for nearly every dose form on the market today. Along with our proprietary dose forms, we also manufacture traditional oral dose forms (tablets, capsules,liquids), sterile dose forms (lyophilization, fill/finish manufacture in vials, ampoules, prefilled syringes, and our innovative "Blow/Fill/Seal" aseptic technology), and topical and inhaled forms. We also produce biologics for pre-clinical and clinical studies, and both clinical and commercial radiopharmaceuticals. We can also help improve yields in commercial biologics production using our proprietary GPEx® technology.

Cardinal Health helps pharmaceutical and biotech companies build strong brand franchises by designing unique packaging solutions that create shelf presence and improve patient compliance. From cartons to promotional materials to printed inserts and labels, we offer expertise and attention to detail.

Toll Free Numbers
North America: 1-866-720-3148
Europe: 44-0-1793-864000

Web site:

Last Updated: 06-22-2006

Key Statistics

Ownership: Public

Web Site: Cardinal Health (North Carolina)
Symbol: CAH

Company News
Cardinal Health, Inc. (CAH) Names Michael C. Kaufmann To Lead Medical Segment Of Healthcare Supply Chain Services 2/19/2007 2:12:35 PM
Cardinal Health, Inc. (CAH) Reports Second-Quarter Results 1/25/2007 3:41:43 PM
Generex Biotechnology Corporation (GNBT) Signs Agreement With Cardinal Health (North Carolina) (CAH) For Generex Oral-lyn(TM) Manufacturing For Clinical Trials 6/22/2006 11:15:49 AM
Cardinal Health, Inc. (CAH) Announces Fiscal 2007 Outlook 6/13/2006 1:18:04 PM
Cardinal Health, Inc. (CAH) CFO To Speak At Goldman Sachs Annual Global Healthcare Conference 6/8/2006 12:55:47 PM
Alpharma Inc. (ALO) Agrees To Sell ParMed Business To Cardinal Health, Inc. (CAH) For $40.1 Million Cash 3/8/2006 4:15:36 PM
Cardinal Health, Inc. (CAH) Unit Receives Subpoena10/19/2005 5:13:14 PM
Cardinal Health, Inc. (CAH) Warns 2005 Profit Could Miss Forecast10/19/2005 5:13:11 PM
Cardinal Health To Release Third Quarter Fiscal 2005 Earnings10/19/2005 5:13:07 PM
Cardinal Health, Inc. (CAH) Chairman And CEO To Speak At Lehman Brothers Eighth Annual Global Healthcare Conference10/19/2005 5:13:06 PM